Cargando…
Lipid lowering therapy in primary and secondary prevention in Austria: are LDL-C goals achieved?: Results from the DA VINCI study
BACKGROUND: Cardiovascular disease (CVD) is the most frequent cause of death in Austria. The European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) guidelines recommend intensive lipid lowering therapy (LLT) in patients at high or very high CV risk. Lipid management and achievem...
Autores principales: | Siostrzonek, Peter, Brath, Helmut, Zweiker, Robert, Drexel, Heinz, Hoelzl, Robert, Hemetsberger, Margit, Ray, Kausik K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023395/ https://www.ncbi.nlm.nih.gov/pubmed/34870742 http://dx.doi.org/10.1007/s00508-021-01978-w |
Ejemplares similares
-
The DA VINCI study: is Ireland achieving ESC/EAS guideline–directed LDL-C goals?
por: Offiah, Gregory, et al.
Publicado: (2022) -
Low-density lipoprotein cholesterol goal attainment in Germany: Results from the DA VINCI study
por: Gouni-Berthold, Ioanna, et al.
Publicado: (2022) -
Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI
por: Vallejo-Vaz, Antonio J., et al.
Publicado: (2022) -
Leonardo da Vinci /
Publicado: (1983) -
Leonardo da Vinci /
por: García Sánchez, Laura
Publicado: (2001)